2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes - Neoadjuvant Systemic Treatment With Nivolumab and Relatlimab in Surgically Resectable Melanoma"

107 views
July 22, 2024
0 Comments
Login to view comments. Click here to Login
Skin